Immunotherapy and pulmonary toxicities: can concomitant immune-checkpoint inhibitors with radiotherapy increase the risk of radiation pneumonitis?

Eur Respir J. 2018 Jan 4;51(1):1701737. doi: 10.1183/13993003.01737-2017. Print 2018 Jan.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Humans
  • Immunologic Factors
  • Immunotherapy / adverse effects*
  • Immunotherapy / methods
  • Lung / physiopathology*
  • Lung Neoplasms / radiotherapy*
  • Male
  • Melanoma / pathology
  • Melanoma / radiotherapy
  • Neoplasm Metastasis
  • Radiation Pneumonitis / etiology*
  • Radiotherapy / adverse effects*
  • Retrospective Studies
  • Risk
  • Skin Neoplasms / pathology
  • Skin Neoplasms / radiotherapy
  • Spleen / pathology
  • Splenic Neoplasms / secondary

Substances

  • Antibodies, Monoclonal, Humanized
  • Immunologic Factors
  • pembrolizumab